Brief: Incyte And Syndax Announce U.S. Food And Drug Administration (FDA) Approval Of Niktimvo™ (Axatilimab-Csfr) 9 mg And 22 mg Vial Sizes

Syndax Pharmaceuticals

15/01/2025 22:36

Jan 15 (Reuters) - Incyte  INCY.O :
    * INCYTE AND SYNDAX ANNOUNCE U.S. FOOD AND DRUG
ADMINISTRATION
(FDA) APPROVAL OF NIKTIMVO™ (AXATILIMAB-CSFR) 9 MG AND 22 MG
VIAL SIZES
    * INCYTE CORP - NIKTIMVO EXPECTED TO BE AVAILABLE IN U.S. IN
EARLY
FEBRUARY

Source text:  ID:nPn89Yzvya 
Further company coverage:  INCY.O 

 ((Reuters.Briefs@thomsonreuters.com;))